Trazodone hydrochloride—a serotonin antagonist and reuptake inhibitor (SARI) originally developed as a human antidepressant—has become one of the most widely prescribed medications in veterinary behavioral medicine. Prescribed primarily off-label for dogs, trazodone is used to manage situational anxiety (such as during veterinary visits, grooming, travel, thunderstorms, and fireworks) and to facilitate post-operative confinement and cage rest following major orthopedic or soft-tissue surgeries. (For a general overview of its clinical uses and dosing concepts, see our trazodone for dogs guide; this article serves as the data-anchored safety and side-effects companion.)

Because trazodone is a human-labeled medication, its use in animals is off-label (extra-label), meaning the FDA has not evaluated its safety and efficacy specifically for canine patients. However, under the Animal Medicinal Drug Use Clarification Act (AMDUCA), veterinarians legally prescribe it to manage behavioral disorders. As its popularity has grown, so has its footprint in post-marketing surveillance. An analysis of the FDA's Center for Veterinary Medicine (CVM) adverse-event database yields 1,617 unique reports naming trazodone.

This guide provides a detailed, data-anchored review of trazodone side effects in dogs. We examine the drug’s pharmacological mechanism, analyze the 1,617 FDA reports, explain the counterintuitive phenomenon of paradoxical excitement, outline the clinical warning signs and drug interactions associated with serotonin syndrome, and detail the emergency triage protocols for accidental overdoses.

---

What is trazodone and is it an FDA-approved dog drug?

Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) belonging to the phenylpiperazine class of compounds. It is not FDA-approved for use in veterinary medicine. Trazodone is approved by the FDA for the treatment of major depressive disorder in humans. Consequently, all veterinary use of trazodone in dogs and cats is off-label.

The Mechanism of Action: SARI Profile

To understand both the therapeutic effects and the side-effect profile of trazodone, it is necessary to examine its multi-receptor mechanism of action in the central nervous system. Unlike selective serotonin reuptake inhibitors (SSRIs like fluoxetine) or tricyclic antidepressants (TCAs like clomipramine), which primarily block serotonin transporters, trazodone acts on multiple serotonin receptors:

1. 5-HT2A Receptor Antagonism: At clinical doses, trazodone acts as a potent antagonist at the 5-HT2A receptor. Blockade of this receptor is the primary driver of the drug's anti-anxiety (anxiolytic) and sedative effects.
2. Serotonin Reuptake Inhibition: Trazodone acts as a moderate inhibitor of the serotonin transporter (SERT), preventing the reuptake of serotonin into the pre-synaptic neuron and increasing serotonin concentrations in the synaptic cleft.
3. 5-HT1A Partial Agonism: Trazodone acts as a partial agonist at the 5-HT1A receptor, a pathway that directly modulates mood and fear responses, further contributing to its anxiolytic properties.
4. Alpha-1 Adrenergic Receptor Antagonism: Trazodone is a potent antagonist at peripheral alpha-1 adrenergic receptors. This blockade causes vasodilation, which can manifest clinically as mild hypotension (low blood pressure) or transient reflex tachycardia.
5. Histamine H1 Receptor Antagonism: Trazodone has moderate antihistamine activity, which contributes to its sedative properties.

---

What are the common trazodone side effects in dogs — and why can it cause paradoxical excitement?

While most dogs tolerate trazodone well, its complex neurochemical activity can produce a range of physiological and behavioral side effects.

Common Clinical Side Effects

Common side effects typically appear within 1 to 3 hours of drug administration, coinciding with peak plasma concentrations:

• Sedation and Lethargy: The most common effect, which is often the desired clinical goal (e.g., for post-op cage rest). However, excessive sedation—where the dog is completely unresponsive or difficult to rouse—is considered an adverse event.
• Gastrointestinal Upset: Vomiting, diarrhea, soft stools, and decreased appetite. These signs are usually mild and resolve as the drug is cleared.
• Ataxia (Wobbliness): The dog may appear uncoordinated, sway while standing, or have difficulty navigating stairs. This is a common extension of the sedative and muscle-relaxing properties of the drug.
• Panting: Increased, shallow breathing that is unrelated to ambient temperature or physical exertion. This is believed to be linked to the drug's effect on central thermoregulation and alpha-adrenergic vasodilation.

The Paradoxical Excitement Phenomenon

A counterintuitive and distressing side effect for pet owners is paradoxical excitement (sometimes referred to as paradoxical agitation or behavioral disinhibition). Instead of becoming calm and sedated, the dog becomes hyperactive, restless, vocal (whining or barking), and exhibits increased pacing or panting.

Why does a sedative trigger agitation? The exact mechanism is not fully understood, but pharmacologists believe it is linked to two factors:

1. m-Chlorophenylpiperazine (mCPP) Metabolite: In dogs, trazodone is metabolized in the liver via cytochrome P450 enzymes into several metabolites, including mCPP. mCPP is a non-selective serotonin receptor agonist (specifically acting on 5-HT2C receptors). In humans and dogs, mCPP is known to induce anxiety, restlessness, and locomotor activity. If a dog metabolizes trazodone rapidly into mCPP, or has a high sensitivity to this metabolite, the agitating effects of mCPP can overwhelm the anxiolytic effects of parent trazodone.
2. Behavioral Disinhibition: Like alcohol or benzodiazepines in humans, low doses of sedatives can suppress the frontal-lobe inhibitory pathways that control fear and social boundaries. If a dog's underlying anxiety is high, suppressing these inhibitory pathways can cause the anxiety to manifest as active panic, agitation, or aggression rather than quiet sedation.

If a dog exhibits paradoxical excitement, the drug should not be repeated. The owner should consult the veterinarian to discuss alternative medications.

---

What do 1,617 FDA adverse-event reports show about trazodone in dogs?

To quantify the post-marketing safety data for trazodone, we analyzed the FDA/CVM openFDA animal adverse-event database using the local snapshot dated July 5, 2026.

Filtering the dataset for records containing "trazodone" and deduplicating by unique_aer_id_number yielded 1,617 unique reports.

[!IMPORTANT] Understanding Spontaneous Reporting Limitations Spontaneous reports represent reporting volume, not clinical incidence. Because they are voluntarily submitted, they cannot prove direct causality in every case, nor do they record the denominator of how many thousands of dogs took trazodone safely. Furthermore, because trazodone is frequently used as a post-operative sedative or behavior modifier in dogs undergoing other medical treatments, many reports represent polypharmacy interactions or the progression of underlying diseases rather than direct trazodone toxicity.

Species and Outcome Distribution

The species distribution in the 1,617 reports is canine-dominant:

• Dogs: 1,594 reports (98.6% of the dataset)
• Cats: 16 reports (reflecting off-label use in feline behavior/sedation)
• Humans: 6 reports (accidental exposures)
• Other: 1 report (unspecified)

The outcomes recorded across the 1,617 reports reflect the transient nature of most behavioral side effects:

• Ongoing: 675 reports (still resolving or being treated at the time of the report)
• Recovered/Normal: 391 reports
• Outcome Unknown: 359 reports
• Euthanized: 113 reports
• Died: 72 reports
• Recovered with Sequela: 5 reports

The death and euthanasia reports (72 Died plus 113 Euthanized = 185, 11.4% of the dataset) must be interpreted with caution. In many cases, these represent end-stage illness, severe concurrent post-operative complications (such as a dog that fractured a repair and had to be euthanized), or severe accidental overdoses where the dog chewed the entire bottle.

The Reaction Spectrum

An analysis of the specific clinical signs (reactions) recorded across the 1,617 deduplicated reports reveals a clear neuro-behavioral and gastrointestinal signature:

Clinical Reaction	FDA Report Count	Organ System / Category
Vomiting	335	Gastrointestinal
Diarrhea	200	Gastrointestinal
Lethargy	260 (combined)	Systemic / Sedation
Decreased Appetite / Not Eating	229 (combined)	Gastrointestinal
Death by Euthanasia	111	Outcome
Seizure NOS	106	Neurological
Lack of Efficacy	99	Therapeutic Failure
Panting	93	Cardiorespiratory / Thermoregulation
Elevated ALT	89	Hepatic (Liver)
Weight Loss	81	Systemic
Death	66	Outcome
Anorexia	71	Gastrointestinal

Key Clinical Insights from the Data

1. Lack of Efficacy (99 reports): A common complaint is that the drug did not work. This is a known challenge with behavior drugs. Behavioral responses are highly variable, and trazodone may fail to sedate a highly agitated or reactive dog, especially if the dose is too low or administered after the dog has already reached a state of high arousal.
2. Seizures (106 reports): Seizure NOS is present. In veterinary literature, trazodone is generally considered safe, but it can lower the seizure threshold in dogs with pre-existing epilepsy. Veterinarians use caution when prescribing it to dogs with a history of seizures.
3. Hepatic Signal (ALT 89 / ALP 65): Mild elevations in liver enzymes are recorded. Trazodone is metabolized in the liver, and while clinical hepatotoxicity is extremely rare, baseline and periodic bloodwork is recommended for dogs on long-term daily therapy.
4. Panting (93 reports): Panting is a recognized reaction, validating owner reports that their dogs pant heavily after taking the drug.

Peer-Reviewed Literature Context

The FDA dataset counts should be compared with peer-reviewed clinical studies. In a study led by Dr. Margaret Gruen (North Carolina State University, published in the Journal of the American Veterinary Medical Association, 2014; PMC4414248) evaluating trazodone for post-surgical confinement in dogs, at least one adverse event was recorded in 55.5% of dogs (20 of 36). The reported events were mild and included somnolence and drowsiness, soft stools or diarrhea, panting, increased thirst, and restlessness or agitation; a smaller number of dogs showed aggression, moaning, or teeth chattering.

Crucially, no dog in the cohort developed serotonin syndrome, priapism, or ongoing akathisia, and no dog was withdrawn from the study for an adverse event. This peer-reviewed profile matches the patterns in the openFDA dataset: sedation, GI upset, and agitation are the primary risks, while serotonin syndrome remains rare and is driven by drug interactions rather than trazodone alone.

---

What is serotonin syndrome, which drug combinations cause it, and how is it treated?

The most critical safety concern associated with trazodone is serotonin syndrome (serotonin toxicity). This is a hyperserotonergic state that occurs when the brain is exposed to excessive levels of serotonin, overloading the serotonin receptors.

Pathophysiology and Causes: Cytochrome P450 and Synaptic Overload

Serotonin syndrome is rarely caused by trazodone administration alone, unless a massive overdose occurs. Instead, it is almost always the result of polypharmacy—combining trazodone with other medications that increase serotonin levels through different mechanisms.

In the dog's body, trazodone is metabolized in the liver primarily via the Cytochrome P450 enzyme system, specifically the CYP3A4 and CYP2D6 subfamilies. When a dog is given other drugs that inhibit these Cytochrome P450 enzymes, trazodone clearance is severely delayed. This results in prolonged systemic concentrations, increasing the likelihood of toxic accumulation.

The drug classes that pose the highest risk when combined with trazodone include:

• SSRIs (Selective Serotonin Reuptake Inhibitors): E.g., fluoxetine (Reconcile) for dogs. Fluoxetine blocks serotonin reuptake and inhibits Cytochrome P450 enzymes, slowing trazodone metabolism.
• TCAs (Tricyclic Antidepressants): E.g., clomipramine (Clomicalm) for dogs — FDA data. Clomipramine blocks serotonin reuptake, compounding synaptic serotonin levels.
• MAOIs (Monoamine Oxidase Inhibitors): E.g., selegiline (Anipryl) for dogs or amitraz (found in some flea/tick collars). MAOIs block the breakdown of serotonin, leading to rapid accumulation.
• Serotonergic Analgesics: E.g., tramadol for dogs. Tramadol is a weak mu-opioid agonist that also inhibits serotonin and norepinephrine reuptake. Combining tramadol and trazodone is a common clinical cause of serotonin syndrome.

Drug / Class	Example Brand	Interaction Mechanism	Serotonin Syndrome Risk
Tramadol	Ultram	Blocks serotonin reuptake + direct serotonergic activity	High (Commonly mixed for post-op pain/rest)
Fluoxetine (SSRI)	Reconcile, Prozac	Blocks serotonin reuptake + inhibits trazodone clearance	High (Requires monitoring when combined)
Clomipramine (TCA)	Clomicalm	Blocks serotonin reuptake	High (Avoid concurrent use unless monitored)
Selegiline (MAOI)	Anipryl	Blocks enzymatic breakdown of serotonin	Critical (Strict contraindication; requires washout)
Corticosteroids	Prednisone	No direct serotonin interaction; increases GI ulcer risk	Low (Standard NSAID rules do not apply)

Clinical Signs of Serotonin Syndrome

Serotonin syndrome is a rapid-onset condition, with signs appearing within 2 to 24 hours of drug exposure. The clinical signs are classified into three categories:

1. Autonomic Hyperactivity: Vomiting, diarrhea, salivation, dilated pupils (mydriasis), rapid heart rate (tachycardia), rapid breathing (tachypnea), and elevated body temperature (hyperthermia/fever).
2. Neuromuscular Abnormalities: Muscle tremors, rigidity, hyperreflexia (exaggerated reflexes), hyperesthesia (extreme sensitivity to touch or sound), wobbly gait (ataxia), and seizures.
3. Mental Status Changes: Restlessness, vocalization, disorientation, and extreme agitation.

The Serotonin Rescue: Cyproheptadine Pharmacology

If serotonin syndrome is diagnosed or suspected, treatment must be initiated immediately. The primary clinical rescue agent is cyproheptadine.

Cyproheptadine is a first-generation antihistamine that also acts as a potent 5-HT1A and 5-HT2 receptor antagonist. By blocking these serotonin receptors, cyproheptadine directly reverses the physiological effects of excess serotonin. It can be administered orally or crushed and given rectally if the dog is actively vomiting or seizing.

Additional treatment consists of supportive care:

• Active Cooling: If hyperthermia is severe (body temperature >103.5°F), using cool water and fans (stopping once temperature reaches 102.5°F to prevent hypothermia).
• Intravenous Fluids: To support cardiovascular stability and assist in drug elimination.
• Anticonvulsants: Benzodiazepines (diazepam, midazolam) to manage muscle tremors and seizures (phenothiazines like acepromazine are avoided as they can worsen hypotension).

---

Why does trazodone sometimes not work, and what do you do instead?

As noted in the FDA dataset (99 reports), lack of efficacy is a common complaint. There are several reasons why trazodone might not work for a specific dog:

The "Arousal" Barrier

Trazodone is a serotonin modulator and mild sedative. It is highly effective at preventing anxiety when administered before the dog becomes stressed. Once a dog is actively panicked (e.g., the fireworks have started, or the dog is already in the vet lobby), the massive release of adrenaline and cortisol overrides the sedative effects of trazodone.

Inadequate Dosing

The published reference range for trazodone in dogs is broad, typically spanning from 2 mg/kg to 10 mg/kg (and occasionally higher in resistant patients). If a dog receives a dose at the lower end of the range, it may show zero clinical effect. Veterinarians often start at a lower dose to evaluate tolerance and then titrate upward. Because trazodone is an off-label human drug with no animal label, the specific dose is set by your veterinarian based on your dog's weight, the situation, and any other medications they take — never dose it yourself, and never combine it with another serotonergic drug without veterinary direction.

Alternative Behavioral Protocols

If trazodone fails to manage a dog's situational anxiety:

• Gabapentin: A neuropathic pain medication that has strong anti-anxiety and sedative properties in dogs and cats. It is often used as an alternative or added alongside trazodone for vet visits.
• Sileo (Dexmedetomidine Oromucosal Gel): An FDA-approved alpha-2 adrenoceptor agonist gel labeled specifically for the treatment of noise aversion (thunderstorms, fireworks) in dogs. It is absorbed through the gums and provides rapid, reliable sedation without the system-wide serotonin risks of trazodone.
• Clomipramine or Fluoxetine: For chronic anxiety (e.g., separation anxiety), a daily medication is preferred over situational trazodone, though trazodone can be used as a "bridge" during the initial 4-to-6 week loading phase of these daily drugs.

---

What should I do if my dog accidentally ate too much trazodone?

Because trazodone is often dispensed in large bottle counts, accidental ingestion (overdose) is a common toxicology emergency.

Toxic Doses and Signs

• Therapeutic Range: 2 to 10 mg/kg orally.
• Mild Toxicity (Doses >20 mg/kg): Excessive sedation, wobbly gait (ataxia), mild hypotension, and vomiting.
• Moderate to Severe Toxicity (Doses >50–100 mg/kg): Pronounced ataxia, disorientation, severe bradycardia (slow heart rate) or tachycardia, hypotension, muscle tremors, seizures, and the development of serotonin syndrome.
• Lethal Dose: No precise lethal dose has been published for dogs; severity scales with the dose ingested, and the most dangerous signs (seizures, hyperthermia, serotonin syndrome) become more likely at the higher end of the exposure range.

Emergency Triage Steps

1. Calculate the Maximum Dose: Locate the bottle, identify the tablet strength (typically 50 mg, 100 mg, or 150 mg), count the missing pills, and calculate the total milligrams. Divide this by your dog's weight in kilograms.
2. Contact Poison Control Immediately: Call your veterinarian, an emergency clinic, or an animal poison control center (ASPCA Animal Poison Control or Pet Poison Helpline).
3. Decontamination (Under Instruction Only): If the ingestion occurred within the last 2 hours and the dog is fully alert, you may be instructed to induce vomiting using 3% hydrogen peroxide. Do not induce vomiting if the dog is already wobbly, lethargic, or showing neurological signs, as this can lead to aspiration.
4. Veterinary Treatment: In a hospital setting, the veterinarian will:
   • Administer activated charcoal to absorb remaining drug.
   • Provide intravenous fluid therapy to maintain blood pressure and renal perfusion.
   • Administer cyproheptadine as a preventative or therapeutic rescue for serotonin syndrome.
   • Monitor heart rate, blood pressure, and neurological status for 24 to 48 hours.

---

Frequently Asked Questions

Is trazodone an FDA-approved medication for dogs?

No. Trazodone is a human medication. It is not FDA-approved for use in animals. Veterinarians prescribe it off-label under the provisions of the Animal Medicinal Drug Use Clarification Act (AMDUCA).

Can I give my dog trazodone with tramadol or fluoxetine?

Combining trazodone with tramadol or fluoxetine increases the risk of serotonin syndrome, a serious and potentially fatal condition. These combinations must only be used under close veterinary supervision with careful monitoring for tremors, fever, and pupil dilation.

Why does trazodone make some dogs more hyper instead of calm?

This is a "paradoxical excitement" reaction. It is a recognized side effect where the drug triggers agitation, restlessness, and hyperactivity instead of sedation. It is believed to be linked to a specific metabolite (mCPP) or behavioral disinhibition.

How long does it take for trazodone to work in dogs?

Trazodone typically takes 1 to 2 hours to take effect. For situational events like vet visits or thunderstorms, it must be administered at least 2 hours before the stressful event to prevent the "arousal barrier" from blocking its efficacy.

What are the signs of serotonin syndrome in a dog?

Signs include vomiting, diarrhea, muscle tremors, rigidity, hyperesthesia (sensitivity to touch), dilated pupils, fever (hyperthermia), rapid heart rate, and extreme agitation or seizures. Cyproheptadine is the clinical rescue agent.

---

Sources

1. Today's Veterinary Nurse / NAVC: Trazodone in Dogs: Benefits and Potential Risks. Retrieved from: https://todaysveterinarynurse.com/toxicology/trazodone-in-veterinary-medicine
2. NCBI PubMed / Journal of the American Veterinary Medical Association: Gruen ME, et al. Use of trazodone to facilitate post-surgical confinement in dogs (2014; JAVMA 245:296-301, PMC4414248). Retrieved from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4414248
3. Veterinary Information Network (VIN) / Veterinary Partner: Trazodone HCL. Retrieved from: https://veterinarypartner.vin.com/doc?id=7756524&pid=19239
4. FDA Center for Veterinary Medicine / openFDA: Animal & Veterinary Adverse Event API Dataset. Retrieved from: https://api.fda.gov/animalandveterinary/event.json
5. American Journal of Animal and Veterinary Sciences: Trazodone: A Review of Its Pharmacological Properties and Tolerance in Dogs and Cats (2017). Retrieved from: https://thescipub.com/pdf/ajavsp.2017.188.194.pdf
6. ASPCA Animal Poison Control Center: Serotonergic Drug Overdose and Toxicity in Companion Animals. Retrieved from: https://www.aspcapro.org/poison